Insider Trading Activity Accelerate Diagnostics, Inc. (NASDAQ:AXDX) – Director Bought 8,200 shares of Stock

Insider Trading Activity For Accelerate Diagnostics, Inc. (NASDAQ:AXDX)

Jack W Schuler , Director of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) reportedly Bought 8,200 shares of the company’s stock at an average price of 21.35 for a total transaction amount of $175,070.00 SEC Form

Insider Trading History For Accelerate Diagnostics, Inc. (NASDAQ:AXDX)

On 6/7/2013 Larry N Feinberg, Major Shareholder, bought 45,508 with an average share price of $8.33 per share and the total transaction amounting to $379,081.64.View SEC Filing

On 6/12/2013 Larry N Feinberg, Major Shareholder, bought 7,175 with an average share price of $8.41 per share and the total transaction amounting to $60,341.75.View SEC Filing

On 6/21/2013 Larry N Feinberg, Major Shareholder, bought 114,250 with an average share price of $8.00 per share and the total transaction amounting to $914,000.00.View SEC Filing

On 8/9/2013 Larry N Feinberg, Major Shareholder, bought 35,168 with an average share price of $7.30 per share and the total transaction amounting to $256,726.40.View SEC Filing

On 8/14/2013 Larry N Feinberg, Major Shareholder, bought 36,814 with an average share price of $7.24 per share and the total transaction amounting to $266,533.36.View SEC Filing

On 8/14/2013 Jack W Schuler, Director, bought 413,090 with an average share price of $8.04 per share and the total transaction amounting to $3,321,243.60.View SEC Filing

On 8/16/2013 Jack W Schuler, Director, bought 78,494 with an average share price of $7.88 per share and the total transaction amounting to $618,532.72.View SEC Filing

Analyst Ratings For Accelerate Diagnostics, Inc. (NASDAQ:AXDX)
These are 2 Buy Ratings .
The current consensus rating for Accelerate Diagnostics, Inc. (NASDAQ:AXDX) is Buy (Score: 3.00) with a consensus target price of $33.00 , a potential (47.32% upside)

Analyst Ratings History For Accelerate Diagnostics, Inc. (NASDAQ:AXDX)

• On 1/29/2016 William Blair Reiterated Rating Buy
• On 8/9/2016 J P Morgan Chase & Co Boost Price Target of rating Overweight with a price target of $17.00 to $25.00
• On 6/5/2017 Piper Jaffray Companies Reiterated Rating Overweight with a price target of $30.00 to $32.00
• On 7/12/2017 BTIG Research Reiterated Rating Buy to Buy with a price target of $34.00

Recent Trading Activity for Accelerate Diagnostics, Inc. (NASDAQ:AXDX)
Shares of Accelerate Diagnostics, Inc. closed the previous trading session at 23.17 up +0.77 3.43% with 260,668 shares trading hands.